Guardion Health Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Guardion Health Sciences generated cash of -$4,369,885, which is more than the previous year. Cash used in financing activities reached the amount of -$5,192,097 last year. Net change in cash is therefore -$9,545,844.
Cash Flow
| 2014 | -543.37K | -7.45K | 534.11K |
|---|---|---|---|
| 2015 | -1.13M | -2.16K | 1.14M |
| 2016 | -1.65M | -3.35K | 1.70M |
| 2017 | -3.40M | -32.38K | 8.10M |
| 2018 | -4.17M | -310.24K | 419.79K |
| 2019 | -6.03M | -171.07K | 16.64M |
| 2020 | -8.01M | -34.73K | 5.45M |
| 2021 | -10.64M | -31.01M | 37.23M |
| 2022 | -7.44M | 4.99M | 14.26M |
| 2023 | -4.36M | 16.13K | -5.19M |
GHSI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.90M | 4.09M | 8.51M | 11.11M | 670.94K | 4.73M | 62.52K | 13.85K | 6.16K | 22.87K |
Operating activities | ||||||||||
Net income | 158.03K | -14.92M | -24.74M | -8.57M | -10.87M | -7.76M | -5.30M | -5.74M | -8.84M | -1.32M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 19.41K | 1.24M | 907.54K | 219.6K | 625.78K | 295.67K | 118.82K | 60.12K | 53.74K | 43.23K |
Stock-based compensation expense | 0 | 307.83K | 1.27M | 0 | 2.71M | 0 | 2.11M | 1.77M | 4.88M | 0 |
| Deferred income tax benefit | 0 | 307.83K | 1.27M | 0 | 2.71M | 0 | 2.11M | 1.77M | 4.88M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -94.28K | 378.68K | 67.08K | -50.13K | 44.56K | -20.99K | -537 | -97 | 537 |
Inventories | 315.65K | -2.80M | 451.12K | -728.80K | 47.05K | -203.26K | -17.43K | -13.43K | -6.33K | 69.54K |
Accounts payable | -903.93K | 1.27M | -680.69K | 479.18K | -14.24K | 102.68K | -121.91K | 84.60K | 76.11K | 0 |
Cash generated by operating activities | -4.36M | -7.44M | -10.64M | -8.01M | -6.03M | -4.17M | -3.40M | -1.65M | -1.13M | -543.37K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -77.59M | -70.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.79K | -5.56K | -74.59K | -40.73K | -171.07K | -310.24K | -37.28K | -3.35K | -2.16K | -7.45K |
Acquisitions Net | 19.93K | -4.99M | -25.94M | 6K | 0 | 0 | 4.89K | 0 | 0 | 0 |
Cash generated by investing activities | 16.13K | 4.99M | -31.01M | -34.73K | -171.07K | -310.24K | -32.38K | -3.35K | -2.16K | -7.45K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 8.83M | 33.66M | 5.45M | 16.22M | 850K | 5.00M | 1.14M | 75K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -308.62K | 0 | 0 | 0 |
Repurchases of common stock | -5.25M | -9.03K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 249.45K | -30.53K | -49K | -151K | 842.5K | -422.5K |
Cash used in financing activities | -5.19M | 14.26M | 37.23M | 5.45M | 16.64M | 419.79K | 8.10M | 1.70M | 1.14M | 534.11K |
Net Change In Cash | -9.54M | 11.81M | -4.42M | -2.59M | 10.44M | -4.06M | 4.67M | 48.67K | 7.69K | -16.71K |
Cash at end of period | 6.35M | 15.90M | 4.09M | 8.51M | 11.11M | 670.94K | 4.73M | 62.52K | 13.85K | 6.16K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |